Annexon   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Francisco CA United States (2011)

Organization Overview

First Clinical Trial
2016
NCT03010046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Annexon Biosciences | Annexon Chief Medical Officer | Annexon Director, Global Clinical Operations | Annexon, Inc. | Annexon Medical Monitor